A case of hyperprolactinemia, probably induced by eletriptan

Julian Davis; Hakki Yilmaz; Mustafa Kaya; Mustafa Özbek; Tuncay Delibaşi

doi:10.5414/CP201744

A case of hyperprolactinemia, probably induced by eletriptan

Julian Davis, Hakki Yilmaz, Mustafa Kaya, Mustafa Özbek, Tuncay Delibaşi

Research output: Contribution to journal › Article › peer-review

Abstract

A 25-year-old woman with a severe migraine begins to use a migraine specific agent, eletriptan (40 mg/d). One month later, she had oligomenorrhea and galactorrhea. We ruled out all causes of hyperprolactinemia. To our knowledge, this is the first published postmarketing case report of eletriptan-induced hyperprolactinemia, presented as oligomenorrhea and galactorrhea in a patient. The Naranjo probability scale indicates a probable relationship between hyperprolactinemia and eletriptan therapy. ©2012 Dustri-Verlag Dr. K. Feistle.

Original language	English
Pages (from-to)	907-908
Number of pages	1
Journal	International Journal of Clinical Pharmacology and Therapeutics
Volume	50
Issue number	12
DOIs	https://doi.org/10.5414/CP201744
Publication status	Published - Dec 2012

Keywords

Adverse affect
Eletriptan
Hyperprolactinemia
Medication

Access to Document

10.5414/CP201744

http://www.dustri.com/nc/journals-in-english/mag/int-journal-of-clinical-pharmacology-and-therapeutics.html

Cite this

@article{798b006194594eb4bc575fd6af1cc603,

title = "A case of hyperprolactinemia, probably induced by eletriptan",

abstract = "A 25-year-old woman with a severe migraine begins to use a migraine specific agent, eletriptan (40 mg/d). One month later, she had oligomenorrhea and galactorrhea. We ruled out all causes of hyperprolactinemia. To our knowledge, this is the first published postmarketing case report of eletriptan-induced hyperprolactinemia, presented as oligomenorrhea and galactorrhea in a patient. The Naranjo probability scale indicates a probable relationship between hyperprolactinemia and eletriptan therapy. {\textcopyright}2012 Dustri-Verlag Dr. K. Feistle.",

keywords = "Adverse affect, Eletriptan, Hyperprolactinemia, Medication",

author = "Julian Davis and Hakki Yilmaz and Mustafa Kaya and Mustafa {\"O}zbek and Tuncay Deliba{\c s}i",

year = "2012",

month = dec,

doi = "10.5414/CP201744",

language = "English",

volume = "50",

pages = "907--908",

journal = "International Journal of Clinical Pharmacology and Therapeutics",

issn = "0946-1965",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "12",

}

TY - JOUR

T1 - A case of hyperprolactinemia, probably induced by eletriptan

AU - Davis, Julian

AU - Yilmaz, Hakki

AU - Kaya, Mustafa

AU - Özbek, Mustafa

AU - Delibaşi, Tuncay

PY - 2012/12

Y1 - 2012/12

N2 - A 25-year-old woman with a severe migraine begins to use a migraine specific agent, eletriptan (40 mg/d). One month later, she had oligomenorrhea and galactorrhea. We ruled out all causes of hyperprolactinemia. To our knowledge, this is the first published postmarketing case report of eletriptan-induced hyperprolactinemia, presented as oligomenorrhea and galactorrhea in a patient. The Naranjo probability scale indicates a probable relationship between hyperprolactinemia and eletriptan therapy. ©2012 Dustri-Verlag Dr. K. Feistle.

AB - A 25-year-old woman with a severe migraine begins to use a migraine specific agent, eletriptan (40 mg/d). One month later, she had oligomenorrhea and galactorrhea. We ruled out all causes of hyperprolactinemia. To our knowledge, this is the first published postmarketing case report of eletriptan-induced hyperprolactinemia, presented as oligomenorrhea and galactorrhea in a patient. The Naranjo probability scale indicates a probable relationship between hyperprolactinemia and eletriptan therapy. ©2012 Dustri-Verlag Dr. K. Feistle.

KW - Adverse affect

KW - Eletriptan

KW - Hyperprolactinemia

KW - Medication

U2 - 10.5414/CP201744

DO - 10.5414/CP201744

M3 - Article

SN - 0946-1965

VL - 50

SP - 907

EP - 908

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

IS - 12

ER -

A case of hyperprolactinemia, probably induced by eletriptan

Abstract

Keywords

Access to Document

Fingerprint

Cite this